Lung cancer is the uncontrolled growth of abnormal cells that start off in one or both lungs; usually in the cells that line the air passages. The abnormal cells do not develop into healthy lung tissue, they divide rapidly and form tumors. As tumors become larger and more numerous, they undermine the lung’s ability to provide the bloodstream with oxygen. Tumors that remain in one place and do not appear to spread are known as “benign tumors”.
Malignant tumors, the more dangerous ones, spread to other parts of the body either through the bloodstream or the lymphatic system. Metastasis refers to cancer spreading beyond its site of origin to other parts of the body. When cancer spreads it is much harder to treat successfully.
Primary lung cancer originates in the lungs, while secondary lung cancerstarts somewhere else in the body, metastasizes, and reaches the lungs. They are considered different types of cancers and are not treated in the same way.
According to the National Cancer Institute, by the end of
2012 there will have been 226,160 new lung cancer diagnoses and 160,340
lung-cancer related deaths in the USA.
According to the World Health Organization (WHO), 7.6
million deaths globally each year are caused by cancer; cancer represents 13%
of all global deaths. As seen below, lung cancer is by far the number one
cancer killer.
·
Lung cancer - 1,370,000 deaths
·
Stomach cancer - 736,000 deaths
·
Liver cancer - 695,000 deaths
·
Colorectal cancer - 608,000 deaths
·
Breast cancer - 458,000 deaths
·
Cervical cancer - 275,000 deaths
The American Cancer Society says that lung cancer makes
up 14% of all newly diagnosed cancers in the USA today. It adds that annually,
more patients die from lung cancer alone than prostate, breast and colon
cancers combined (in the USA). An American man’s lifetime risk of developing
lung cancer is 1 in 13; for a woman the risk is 1 in 16. These risk figures are
for all US adults, including smokers, ex-smokers and non-smokers. The risk for
a regular smoker is dramatically higher.
Most lung cancer patients are over the age of 60 years
when they are diagnosed. Lung cancer takes several years to reach a level where
symptoms are felt and the sufferer decides to seek medical help.
Female lung cancer rates set to rise rapidly
Over the next three decades,female
lung cancer will increase thirty-five times faster than male lung cancer, scientists
from King’s College London reported in October 2012.
In the UK, female lung cancer deaths will reach 95,000
annually in 2040, from 26,000 in 2010 – a rise of more than 350%. Male annual
lung cancer deaths will increase by 8% over the same period, to 42,000 in 2040
from 39,000 in 2010.
The authors of the report say that lung cancer will
continue being the largest cancer killer over the next thirty years. Twice as
many people will be living with lung cancer in 2040 compared to 2010. The main
reason for the increase will be longer lifespans - the older you are, the
higher your risk of cancer is, including lung cancer.
How is lung cancer classified?
Lung cancer can be broadly classified into
two main types based on the cancer's appearance under a microscope: non-small
cell lung cancer and small cell lung cancer. Non-small cell lung cancer (NSCLC)
accounts for 80% of lung cancers, while small cell lung cancer accounts for the
remaining 20%.
NSCLC can be further divided into four
different types, each with different treatment options:
·
Squamous
cell carcinoma or
epidermoid carcinoma. As the most common type of NSCLC and the most common type
of lung cancer in men, squamous cell carcinoma forms in the lining of the
bronchial tubes.
·
Adenocarcinoma. As
the most common type of lung cancer in women and in nonsmokers, adenocarcinoma
forms in the mucus-producing glands of the lungs.
·
Bronchioalveolar
carcinoma. This type of
lung cancer is a rare type of adenocarcinoma that forms near the lungs' air
sacs.
·
Large-cell
undifferentiated carcinoma. A rapidly
growing cancer, large-cell undifferentiated carcinomas form near the outer
edges or surface of the lungs.
Small cell lung cancer (SCLC) is
characterized by small cells that multiply quickly and form large tumors that
travel throughout the body. Almost all cases of SCLC are due to smoking.
What causes cancer?
Cancer is ultimately the result of cells that
uncontrollably grow and do not die. Normal cells in the body follow an orderly
path of growth, division, and death. Programmed cell death is called apoptosis,
and when this process breaks down, cancer begins to form. Unlike regular cells,
cancer cells do not experience programmatic death and instead continue to grow
and divide. This leads to a mass of abnormal cells that grows out of control.
Lung cancer occurs when
a lung cell's gene mutation makes the cell unable to correct DNA damage and
unable to commit suicide. Mutations can occur for a variety of
reasons. Most lung cancers are the result of inhaling carcinogenic substances.
Carcinogens
Carcinogens are a class of substances that
are directly responsible for damaging DNA, promoting or aiding cancer. Tobacco,
asbestos, arsenic, radiation such as gamma and x-rays, the sun, and compounds
in car exhaust fumes are all examples of carcinogens. When our bodies are
exposed to carcinogens, free radicals are formed that try to steal electrons
from other molecules in the body. These free radicals damage cells and affect
their ability to function and divide normally.
About 87% of lung cancers are related to
smoking and inhaling the carcinogens in tobacco smoke. Even exposure to
second-hand smoke can damage cells so that cancer forms.
Genes
Cancer can be the result of a genetic
predisposition that is inherited from family members. It is possible to be born
with certain genetic mutations or a fault in a gene that makes one
statistically more likely to develop cancer later in life. Genetic
predispositions are thought to either directly cause lung cancer or greatly
increase one's chances of developing lung cancer from exposure to certain
environmental factors.
What are the symptoms of lung cancer?
Cancer symptoms are quite varied and depend
on where the cancer is located, where it has spread, and how big the tumor is.
Lung cancer symptoms may take years before appearing, usually after the disease
is in an advanced stage.
Many symptoms of lung
cancer affect the chest and air passages. These include:
·
Persistent or intense coughing
·
Pain in the chest shoulder, or back from
coughing
·
Changes in color of the mucus that is coughed
up from the lower airways (sputum)
·
Difficulty breathing and swallowing
·
Hoarseness of the voice
·
Harsh sounds while breathing (stridor)
·
Chronic bronchitis or pneumonia
·
Coughing up blood, or blood in the sputum
If the lung cancer spreads, or metastasizes,
additional symptoms can present themselves in the newly affected area. Swollen
or enlarged lymph nodes are common and likely to be present early. If cancer
spreads to the brain, patients may experience vertigo, headaches, or seizures.
In addition, the liver may become enlarged and cause jaundice and bones can
become painful, brittle, and broken. It is also possible for the cancer to
infect the adrenal glands resulting in hormone level changes.
As lung cancer cells spread and use more of
the body's energy, it is possible to present symptoms that may also be
associated with many other ailments. These include:
·
Fever
·
Fatigue
·
Unexplained weight loss
·
Pain in joints or bones
·
Problems with brain function and memory
·
Swelling in the neck or face
·
General weakness
·
Bleeding and blood clots
How is lung cancer diagnosed and staged?
Physicians use information revealed by
symptoms as well as several other procedures in order to diagnose lung cancer.
Common imaging techniques include chest X-rays, bronchoscopy (a thin tube with
a camera on one end), CT scans, MRI scans, and PET scans.
Physicians will also conduct a physical examination, a
chest examination, and an analysis of blood in the sputum. All of these
procedures are designed to detect where the tumor is located and what
additional organs may be affected by it.
Although the above diagnostic techniques provided
important information, extracting cancer cells and looking at them under a
microscope is the only absolute way to diagnose lung cancer. This procedure is
called a biopsy. If the biopsy confirms lung cancer, a pathologist will
determine whether it is non-small cell lung cancer or small cell lung cancer.
After a diagnosis is made, an oncologist will determine
the stage of the cancer by finding out how far the cancer has spread. The stage
determines which choices will be available for treatment and informs prognosis.
The most common cancer staging method is called the TNM system. T (1-4)
indicates the size and direct extent of the primary tumor, N (0-3) indicates
the degree to which the cancer has spread to nearby lymph nodes, and M (0-1)
indicates whether the cancer has metastasized to other organs in the body. A
small tumor that has not spread to lymph nodes or distant organs may be staged
as (T1, N0, M0), for example.
For non-small cell lung cancer, TNM descriptions lead to
a simpler categorization of stages. These stages are labeled from I to IV,
where lower numbers indicate earlier stages where the cancer has spread less.
More specifically:
·
Stage
I is when the tumor is found only in one lung and in no lymph nodes.
·
Stage
II is when the cancer has spread to the lymph nodes surrounding the infected
lung.
·
Stage
IIIa is when the cancer has spread to lymph nodes around the trachea, chest
wall, and diaphragm, on the same side as the infected lung.
·
Stage
IIIb is when the cancer has spread to lymph nodes on the other lung or in the
neck.
·
Stage
IV is when the cancer has spread throughout the rest of the body and other
parts of the lungs.
Small
cell lung cancer has two stages: limited or extensive. In the limited stage,
the tumor exists in one lung and in nearby lymph nodes. In the extensive stage,
the tumor has infected the other lung as well as other organs in the body.
No comments:
Post a Comment